See More. Fail Less. Discover Faster.
Our Mission
We empower scientists to unlock the full story of drug action by revealing both uptake and response in every single cell.
With DrugSeq Solutions, pharma, biotech, and academic teams gain the clarity to identify resistance early, optimize therapies faster, and bring safer, more effective treatments to patients.
Pharma & Biotech
Problem
Drug development is slowed down by costly failures when resistant subpopulations or off-target effects emerge too late. Conventional tools cannot distinguish between lack of exposure and true resistance at the single-cell level.
​
​
​
​
​
DrugSeq Solutions provides dual readouts — drug uptake + molecular response per cell — enabling pharma teams to identify resistance early, optimize dosing, and make confident Go/No-Go decisions sooner, reducing R&D costs and timelines.
Our solution
Contract Research Organizations
CROs face increasing demand for advanced single-cell assays but often lack differentiated offerings beyond standard sequencing or imaging.
​
​
​
​
​
​
​
By integrating DrugSeq Solutions, CROs can expand their service portfolio with next-generation single-cell pharmacology. Our platform plugs directly into 10x Genomics workflows, giving CROs a scalable, high-value service that attracts new clients and strengthens partnerships.
Our solution
Problem
Academic Labs
Researchers studying drug mechanisms struggle to directly link compound exposure to cellular response. Existing assays either alter the drug or fail to capture single-cell heterogeneity.
​
​
​
​
​
​
​DrugSeq Solutions enables academics to preserve native drug activity while gaining unprecedented insight into how individual cells respond. This opens new avenues for mechanistic studies, resistance biology, and innovative grant proposals.
Our solution
Problem